Winoglip-20 – Teneligliptin 20mg Tablets (5’s) | Type 2 Diabetes Treatment

Description

Winoglip-20 Tablets (5’s) | Teneligliptin 20mg | For Type 2 Diabetes Management

Category: Anti-diabetic (DPP-4 Inhibitor)
Pack Size: 5 Tablets (1 strips of 5 tablets each)

Composition (Per Tablet):

• Teneligliptin Hydrobromide Hydrate 20mg

Key Benefits:
✔️ Long-Lasting DPP-4 Inhibition: Provides 24-hour glycemic control
✔️ Low Hypoglycemia Risk: Glucose-dependent insulin secretion
✔️ Weight-Neutral: No significant weight gain
✔️ Renal Safety: No dose adjustment required in renal impairment

Therapeutic Uses:
• Type 2 diabetes mellitus as monotherapy
• Combination therapy with other antidiabetics
• Elderly patients with renal concerns
• Patients needing once-daily convenience

Dosage (Adults):

• 1 tablet (20mg) once daily with or without food

• Consistent Timing: Take at the same time each day

• No Renal Adjustment: Safe across all renal function levels

Safety Profile:
🚫 Contraindications:

• Type 1 diabetes mellitus

• Diabetic ketoacidosis

• Hypersensitivity to teneligliptin

⚠️ Monitor For:
• Mild nasopharyngitis
• Constipation (rare)
• Hypoglycemia when combined with sulfonylureas

Drug Interactions:
▲ Significant Interactions:

• Strong CYP3A4 inducers (may reduce efficacy)

• Insulin/secretagogues (increased hypoglycemia risk)

Storage:

• Below 30°C

• Protect from moisture and light

• Keep in original packaging